Cardiovascular disease assay kit DR1037

cardiac troponin Ibloodserum

hs-cTnI is a myocardial marker used to detect the extent of myocardial damage and diagnose myocardial infarction. The full name of hs-cTnI is high-sensitivity cardiac troponin I (high-sensitivity cardiac troponin I). It is a protein molecule released into the blood after myocardial cells are damaged and is used to evaluate the diagnosis and treatment of heart disease. [INTENDED USE] The kit has been designed for the quantitative determination of Cardiac Troponin I (cTnI) in human serum. The method can be used for samples over the range of 0.02-100.00 ng/mL. 【Expected usage】 For the quantitative detection of troponin I (cTnI) in human serum in vitro. Cardiac troponin (cTn) (including cTnI and cTnT) in acute coronary It also has important clinical implications in the risk stratification of ACS. When the myocardial cell membrane is intact, cTnI and cTnT cannot penetrate the cell membrane and enter the blood circulation, so the blood of healthy people does not contain or contain very low amounts of cTnI and cTnT. , cTnT diffused into the interstitium and appeared earlier in peripheral blood. Cardiac troponin appears earlier (3-12 hours) after the onset, lasts for a long time (4-10 days), and has high sensitivity and specificity for myocardial injury. It is currently the best definite marker for the diagnosis of AMI thing. Troponin I is a specific and sensitive marker for detecting myocardial injury. Elevated levels of troponin (above the cutoff value) within 4-12 hours of acute myocardial ischemia have high specificity and sensitivity for the diagnosis of acute myocardial infarction.According to the ESC and ACC Common Protocol - Redefinition of Myocardial Infarction